Growth Metrics

Fulgent Genetics (FLGT) Operating Leases (2019 - 2026)

Fulgent Genetics' Operating Leases history spans 7 years, with the latest figure at $6.0 million for Q1 2026.

  • On a quarterly basis, Operating Leases rose 54.33% to $6.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $6.0 million, a 54.33% increase, with the full-year FY2025 number at $3.8 million, down 8.23% from a year prior.
  • Operating Leases hit $6.0 million in Q1 2026 for Fulgent Genetics, up from $3.8 million in the prior quarter.
  • Over the last five years, Operating Leases for FLGT hit a ceiling of $8.8 million in Q4 2022 and a floor of $3.6 million in Q3 2025.
  • Historically, Operating Leases has averaged $5.4 million across 5 years, with a median of $4.7 million in 2024.
  • Biggest five-year swings in Operating Leases: crashed 47.38% in 2025 and later skyrocketed 54.33% in 2026.
  • Tracing FLGT's Operating Leases over 5 years: stood at $8.8 million in 2022, then decreased by 18.74% to $7.1 million in 2023, then crashed by 42.35% to $4.1 million in 2024, then fell by 8.23% to $3.8 million in 2025, then surged by 58.9% to $6.0 million in 2026.
  • Business Quant data shows Operating Leases for FLGT at $6.0 million in Q1 2026, $3.8 million in Q4 2025, and $3.6 million in Q3 2025.